Medindia

X

Cipla Soon to Launch Generic Hepatitis C Drug as Hepcvir

by Julia Samuel on  March 26, 2015 at 7:11 PM Drug News   - G J E 4
The generic drug Sofosbuvir for treating chronic Hepatitis C in India is soon to be launched under the brand name 'Hepcvir'.

"Sofusbuvir marks a new era of medicines in oral treatment of Hepatitis C which reduce the need for injectables," Cipla Chief Medical Officer Jaideep Gogtay said.
Cipla Soon to Launch Generic Hepatitis C Drug as Hepcvir
Cipla Soon to Launch Generic Hepatitis C Drug as Hepcvir
Advertisement

Cipla has signed a licensing agreement with Gilead to manufacture the drug Sofosbuvir and it will be made available to Indian patients in a week's time.

Advertisement
"Cipla has always brought accessible and affordable medicines to fight against diseases like AIDS and Hepatitis B; hence, Cipla has made it a priority to bring Hepcvir to patients in India as well as the other developing nations," Cipla MD & Global CEO Subhanu Saxena said.

Dr Reddy's entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All